跳至主要内容
临床试验/EUCTR2014-001661-27-ES
EUCTR2014-001661-27-ES进行中(未招募)1 期

Comparison of TIcagrelor and clopidogrel in patients with Coronary artery diseaSe and type 2 Diabetes Mellitus (TICS-DM): a randomized pharmacodynamic study - TICS-DM

Sociedad Española de Cardiología0 个研究点开始时间: 2014年10月16日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Provision of informed consent prior to any study specific procedures
  • 2. Age between 18 and 75 years
  • 3. Type 2 diabetes mellitus according to ADA criteria
  • 4. Angiographically documented coronary artery disease
  • 5. Chronic treatment (>1 month) with aspirin (100mg/day)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • 1. Known allergies to aspirin, clopidogrel, or ticagrelor
  • 2. Blood dyscrasia or bleeding diathesis
  • 3. Any recent acute coronary syndrome (<30 days) or hemodinamic instability
  • 4. Recent antiplatelet therapy (<14 days), with the exception of ASA, including: thienopyridines, cilostazol, dipiridamol, glycoprotein IIb/IIIa inhibitors
  • 5. Oral anticoagulation with a coumarin derivative
  • 6. Any active bleeding
  • 7. Recent history of stroke, transient ischemic attack or intracranial bleeding (<6 months prior to inclusion)
  • 8. Platelet count <100x106/microl
  • 9. Any active neoplasm
  • 10. Severe chronic kidney disease (creatinine clearance measured with Cockcroft-Gault formula <30ml/min)
  • 11. Baseline ALT >2.5 times the upper limit of normality
  • 12. Pregnant or childbearing females

研究者

发起方
Sociedad Española de Cardiología

相似试验

Comparison of ticagrelor and clopidogrel in patients... | 临床试验